Hypoxia dose painting in SBRT – the virtual clinical trial approach

References

• Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006.
   Google Scholar
• Horsman MR, Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res. 2016;57(Suppl 1):i90–i98. doi:10.1093/jrr/rrw007.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005;77(1):18–24. doi:10.1016/j.radonc.2005.06.038.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol. 2007;25(26):4066–4074. doi:10.1200/JCO.2007.12.7878.
   PubMed Web of Science ®Google Scholar
• Grimes DR, Warren DR, Warren S. Hypoxia imaging and radiotherapy: bridging the resolution gap. Br J Radiol. 2017;90(1076):20160939. doi:10.1259/bjr.20160939.
   PubMed Web of Science ®Google Scholar
• Busk M, Overgaard J, Horsman MR. Imaging of tumor hypoxia for radiotherapy: current status and future directions. Semin Nucl Med. 2020;50(6):562–583. doi:10.1053/j.semnuclmed.2020.05.003.
   PubMed Web of Science ®Google Scholar
• Lindblom E, Antonovic L, Dasu A, et al. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability. Radiat Oncol. 2014;9(1):149. doi:10.1186/1748-717X-9-149.
   PubMedGoogle Scholar
• Lindblom E, Dasu A, Toma-Dasu I. Optimal fractionation in radiotherapy for non-small cell lung cancer–a modelling approach. Acta Oncol. 2015;54(9):1592–1598. doi:10.3109/0284186X.2015.1061207.
   PubMed Web of Science ®Google Scholar
• Schiavo F, Kjellsson Lindblom E, Toma-Dasu I. Towards the virtual tumor for optimizing radiotherapy treatments of hypoxic tumors: a novel model of heterogeneous tissue vasculature and oxygenation. J Theor Biol. 2022;547:111175. doi:10.1016/j.jtbi.2022.111175.
   PubMed Web of Science ®Google Scholar
• Daşu A, Toma-Daşu I, Karlsson M. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys Med Biol. 2003;48(17):2829–2842. doi:10.1088/0031-9155/48/17/307.
   PubMed Web of Science ®Google Scholar
• Lindblom EK, Hui S, Brooks J, et al. Radiation-induced vascular damage and the impact on the treatment outcome of stereotactic body radiotherapy. Anticancer Res. 2019;39(6):2721–2727. doi:10.21873/anticanres.13398.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26(2):225–239. doi:10.1007/s10555-007-9055-1.
   PubMed Web of Science ®Google Scholar
• Kallinowski F, Zander R, Hoeckel M, et al. Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int J Radiat Oncol Biol Phys. 1990;19(4):953–961. doi:10.1016/0360-3016(90)90018-f.
   PubMed Web of Science ®Google Scholar
• Pogue BW, Paulsen KD, O'Hara JA, et al. Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements. Radiat Res. 2001;155(1):15–25. doi:10.1667/0033-7587(2001)155[0015:EOODIR.2.0.CO;2]
   PubMed Web of Science ®Google Scholar
• Daşu A, Toma-Daşu I. Vascular oxygen content and the tissue oxygenation–a theoretical analysis. Med Phys. 2008;35(2):539–545. doi:10.1118/1.2830382.
   PubMed Web of Science ®Google Scholar
• Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 1984;23(5):379–391. doi:10.3109/02841868409136037.
   PubMed Web of Science ®Google Scholar
• Toma-Daşu I, Daşu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol. 2009;48(8):1181–1192. doi:10.3109/02841860903188643.
   PubMed Web of Science ®Google Scholar
• Alper T, Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature. 1956;178(4540):978–979. doi:10.1038/178978a0.
   PubMed Web of Science ®Google Scholar
• Toma-Dasu I, Dasu A. Modelling tumour oxygenation, reoxygenation and implications on treatment outcome. Comput Math Methods Med. 2013;2013:141087–141089. doi:10.1155/2013/141087.
   PubMed Web of Science ®Google Scholar
• Barendsen GW. Dose fraction, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8(11):1981–1997. doi:10.1016/0360-3016(82)90459-x.
   PubMed Web of Science ®Google Scholar
• Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62(740):679–694. doi:10.1259/0007-1285-62-740-679.
   PubMed Web of Science ®Google Scholar
• Dubec MJ, Buckley DL, Berks M, et al. First-in-human technique translation of oxygen-enhanced MRI to an MR linac system in patients with head and neck cancer. Radiother Oncol. 2023;183:109592. doi:10.1016/j.radonc.2023.109592.
   PubMed Web of Science ®Google Scholar
• Oderinde OM, Shirvani SM, Olcott PD, et al. The technical design and concept of a PET/CT linac for biology-guided radiotherapy. Clin Transl Radiat Oncol. 2021;29:106–112. doi:10.1016/j.ctro.2021.04.003.
   PubMedGoogle Scholar
• Kjellsson Lindblom E, Ureba A, Dasu A, et al. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation. Med Phys. 2019;46(5):2512–2521. doi:10.1002/mp.13514.
   PubMed Web of Science ®Google Scholar
• Chvetsov AV, Rajendran JG, Zeng J, et al. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation. Med Phys. 2017;44(5):1975–1982. doi:10.1002/mp.12177.
   PubMed Web of Science ®Google Scholar
• Köthe A, Bizzocchi N, Safai S, et al. Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer. Radiat Oncol. 2021;16(1):199. doi:10.1186/s13014-021-01914-2.
   PubMed Web of Science ®Google Scholar
• Yang J, Fowler JF, Lamond JP, et al. Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;77(3):903–909. doi:10.1016/j.ijrobp.2009.12.069.
   PubMed Web of Science ®Google Scholar
• Ureba A, Kjellsson Lindblom E, Toma-Dasu I, et al. Assessment of the probability of tumour control for prescribed doses based on imaging of oxygen partial pressure. Adv Exp Med Biol. 2021;1269:185–190.
   PubMed Web of Science ®Google Scholar
• Schiavo F, Toma-Dasu I, Lindblom EK. Perfusion-Limited hypoxia determines the outcome of radiation therapy of hypoxic tumours. Adv Exp Med Biol. 2022;1395:249–254. doi:10.1007/978-3-031-14190-4_41.
   PubMedGoogle Scholar
• Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300(5622):1155–1159. doi:10.1126/science.1082504.
   PubMed Web of Science ®Google Scholar
• Lindblom EK, Dasu A, Toma-Dasu I. Hypoxia induced by vascular damage at high doses could compromise the outcome of radiotherapy. Anticancer Res. 2019;39(5):2337–2340. doi:10.21873/anticanres.13350.
   PubMed Web of Science ®Google Scholar